Cholinergic Mechanisms in Lewy Body Dementia
路易体痴呆的胆碱能机制
基本信息
- 批准号:10662018
- 负责人:
- 金额:$ 52.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcetylcholineAlzheimer&aposs DiseaseAnatomyAnimal ModelAttentionBasal CellBehavioralBrainBrain regionCell NucleusCellsCognitionCognitiveDataData CorrelationsDementiaDementia with Lewy BodiesElectrophysiology (science)Executive DysfunctionFunctional disorderGlutamatesImpaired cognitionImpairmentLeadLewy BodiesLewy Body DementiaLewy neuritesLinkLong-Term DepressionMeasuresMedialModelingMusMuscarinic Acetylcholine ReceptorNeuronsNeurotransmittersNicotinic ReceptorsOutputParkinson DiseaseParkinson&aposs DementiaPathologicPatientsPrefrontal CortexPropertyPyramidal CellsRegulationRoleSeriesSignal TransductionSourceSymptomsSynapsesSynaptic plasticitySystemTestingalpha synucleinbasal forebraincholinergiccomparison controldesigner receptors exclusively activated by designer drugsexecutive functionexperimental studyflexibilityhippocampal pyramidal neuroninsightmouse modelnervous system disorderneuron lossneuronal circuitryneuronal excitabilityneuroregulationnovel therapeutic interventionnovel therapeuticspharmacologicpostsynapticpre-formed fibrilpresynapticreceptorsynucleinopathy
项目摘要
Project Summary/Abstract
Accumulation of α-synuclein (α-syn) into Lewy Bodies and Lewy Neurites is a hallmark of the Lewy Body
Dementias (LBD), Dementia with Lewy Bodies and Parkinson’s Disease-Dementia. Additionally, some brain
regions in Alzheimer’s Disease have pathological α-syn. Therefore, α-syn is likely a major cause of cognitive
decline across several dementias. One possible mechanism underlying the core cognitive impairments centered
around impaired executive function in LBD may be loss or dysfunction of projection neurons from the basal
forebrain that produce acetylcholine (ACh). Across LBD, there is profound loss of cholinergic cells of the basal
forebrain, which project to the prelimbic medial prefrontal cortex (PL-mPFC), a known key brain nucleus for
executive function. Basal forebrain ACh acts through nicotinic and muscarinic ACh receptors (mAChR) to
modulate PL-mPFC glutamatergic projection neurons critical for normal executive function. Recent evidence has
further refined the mechanisms by which ACh regulates the PL-mPFC, and has suggested a key role for the M1
mAChR in regulating executive function. Despite this critical neuromodulatory role of ACh and M1 in the PL-mPFC
in executive function, there are few studies that examine this important relationship in the context of α-syn related
dementias. This has led to our overall hypothesis that cognitive decline in the context of α-syn linked
dementias results from disrupted ACh signaling in the mPFC. We have used the pre-formed fibril (PFF)
model of α-synucleinopathies to show that inputs into the PL-mPFC show enhanced ACh dependent long term
depression in PFF injected mice. Additionally, layer 5 pyramidal cells of the PL-mPFC show decreased excitability
in PFF injected mice compared to controls that may be attributable to ACh dependent changes in intrinsic
properties of these cells. This suggests that α-syn dysregulates multiples aspects of the PL-mPFC through
alterations in ACh release or signaling. To rigorously test this, we will perform a series of electrophysiology and
behavioral experiments to determine, define, and dissect how α-ayn dysregulates the PL-mPFC through loss of
ACh signaling or release. In Aim 1, we will test the hypothesis that α-syn dysregulates PL-mPFC inputs through
altering ACh signaling. In Aim 2, we will test the hypothesis that α-syn alters intrinsic properties and output of PL-
mPFC projection neurons through loss of ACh signaling. In aim 3, we will test the hypothesis that boosting
cholinergic signaling will rescue deficits in executive function. Completion of these aims will provide fundamental
understanding of how α-syn dysregulates ACh signaling to impair executive function in LBD.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark S Moehle其他文献
Mark S Moehle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark S Moehle', 18)}}的其他基金
M4 muscarinic acetylcholine receptor signaling as a potent regulator of motor deficits
M4 毒蕈碱乙酰胆碱受体信号传导作为运动缺陷的有效调节剂
- 批准号:
10584466 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
M4 muscarinic acetylcholine receptor signaling as a potent regulator of motor deficits
M4 毒蕈碱乙酰胆碱受体信号传导作为运动缺陷的有效调节剂
- 批准号:
10336602 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
M4 muscarinic acetylcholine receptor signaling as a potent regulator of motor deficits
M4 毒蕈碱乙酰胆碱受体信号传导作为运动缺陷的有效调节剂
- 批准号:
10369057 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
M4 muscarinic acetylcholine receptor signaling as a potent regulator of motor deficits
M4 毒蕈碱乙酰胆碱受体信号传导作为运动缺陷的有效调节剂
- 批准号:
9891115 - 财政年份:2019
- 资助金额:
$ 52.61万 - 项目类别: